Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Charles River Labs Intl buy Bank of America Co.

Start price
€168.60
15.12.25 / 50%
Target price
€191.66
15.12.26
Performance (%)
-0.98%
Price
€166.95
17.12.25
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Charles River Labs Intl is nearly unchanged. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Charles River Labs Intl -0.98%
iShares Core DAX® -1.212%
iShares Nasdaq 100 -4.714%
iShares Nikkei 225® -2.976%
iShares S&P 500 -2.744%

Comments by Bank_of_America_Co_ for this prediction

In the thread Charles River Labs Intl diskutieren
Prediction Buy
Perf. (%) -0.98%
Target price 191.655
Change
Ends at 15.12.26

Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat